AVEVA Drug Delivery Systems is a global leader in transdermal drug delivery located in the US. The company has an extensive history of providing pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs or supply high-quality, affordable brand equivalents.
By leveraging this experience, AVEVA offers a full range of research, development and manufacturing capabilities to produce transdermal pharmaceutical products that can improve the quality of life, usage and compliance rates for patients.
AVEVA uses a number of sophisticated technologies to produce proprietary and generic transdermal drug delivery systems that fortify R&D pipelines and enhance compounds by:
Commercial successes can be found in the following therapeutic categories:
Approved AVEVA products:
AVEVA’s deal configurations are designed for maximum flexibility in accordance with the needs of partners, and are as unique to each client as AVEVA’s customized transdermal drug delivery systems:
At AVEVA Drug Delivery Systems, we don’t employ just one process in the development of transdermal drug delivery systems.
AVEVA creates individualized systems that are specifically designed for the chemical entity, rapidly and cost-effectively generating unique products to meet specialized needs.
AVEVA clearly recognizes and understands the need for leading-edge capabilities and innovative technologies in order to open up a growing pool of new pharmaceutical compounds for transdermal drug delivery.
Aveva Drug Delivery Systems
3250 Commerce Parkway
Miramar, Florida 33025
Tel: + 1-954-430-3340
Fax: + 1-954-430-3390
Robert J. Bloder
Vice President, Business Development